Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk.
Cardiovascular disease (CVD), such as coronary heart disease (CHD), is the most frequent cause of death worldwide, especially in developed countries. The latest recommendations of European and American Cardiological Associations emphasize the role of non-HDL cholesterol (non-HDL-C) in evaluating the risk of CVD. Although this parameter has a lot of advantages, it is rarely used by general practitioners in lipid profile assessment. The aim of this article is to present the recent informations on the usage of non-HDL-C in the primary prevention of cardiovascular disease and to compare its diagnostic value to traditional and new CVD risk factors.
PhD student, Department of Laboratory Medicine, Collegium Medicum, Nicolaus Copernicus University , Bydgoszcz, Poland.
Katarzyna
K
Bergmann
Indian J Clin Biochem. 2006 Mar;21(1):181-4
23105595
Curr Vasc Pharmacol. 2005 Jan;3(1):63-8
15638783
Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:S1-113
17726407
Southeast Asian J Trop Med Public Health. 2009 May;40(3):581-92
19842447
Am J Cardiol. 2009 Aug 15;104(4):548-53
19660610
Eur Heart J. 2005 Feb;26(3):271-8
15618061
Circulation. 2005 Nov 29;112(22):3366-7
16316960
J Am Coll Cardiol. 2009 Jan 27;53(4):316-22
19161879
J Lipid Res. 2007 Nov;48(11):2499-505
17698856
Diabetes Care. 2005 Aug;28(8):1916-21
16043732
Arterioscler Thromb Vasc Biol. 2008 Sep;28(9):1582-3
18716322
Atherosclerosis. 2009 Jan;202(1):289-95
18452924
Pediatrics. 2008 May;121(5):924-9
18450895
Circulation. 2005 Nov 29;112(22):3375-83
16316964
Vasc Health Risk Manag. 2009;5:757-65
19774217
J Atheroscler Thromb. 2008 Jun;15(3):116-21
18603817
J Clin Biochem Nutr. 2008 Jul;43(1):1-5
18648653
J Atheroscler Thromb. 2005;12 (3):143-8
16020914
Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):661-70
17170368
Biochem Soc Trans. 2001 May;29(Pt 2):358-62
11356183